Shanghai Pharmaceuticals (HKG:2607, SHA:601607) posted 1.08 billion yuan in attributable net profit for the third quarter, up 57% from a year ago.

EPS moved to 0.29 yuan, an increase of 53% year over year, a Thursday filing with the Hong Kong Exchange showed.

For the three months ended Sept. 30, operating revenue was 75.49 billion yuan, up 3% from a year earlier, the pharmaceutical and healthcare giant said.